NACDS continues support of drug safety bill
ALEXANDRIA, Va. An organization representing the nation’s drug stores praised a House subcommittee’s legislation that related to the safety of prescription drugs and the security of the drug supply chain.
The National Association of Chain Drug Stores responded Tuesday to a "discussion draft" of drug safety legislation advocated by Reps. John Dingell, D-Mich.; Henry Waxman, D-Calif.; Frank Pallone, D-N.J.; and Bart Stupak, D-Mich., all of whom are members of the House of Representatives’ Energy and Commerce Committee.
NACDS supported such provisions of the bill as the inclusion of increasing inspections of producers of drugs and active ingredients inside and outside of the United States; requiring parity between foreign and domestic inspections; prohibiting the entry of drugs that lack appropriate safety documentation; and requiring that manufacturers have quality risk management plans.
“Pharmacy is committed to supporting efforts to maintain and enhance the quality and safety of our nation’s drug supply. Nothing is more important to pharmacy than the health and safety of patients, and we take this obligation very seriously,” said NACDS president and CEO Steve Anderson. “This draft bill includes a focus on strong steps that would be effective in further enhancing prescription drug safety. NACDS thanks these leaders of the House Energy and Commerce Committee for their vigilance, and NACDS will remain actively engaged in the discussion and work of advancing patient safety, a top priority of pharmacy.”
Sanofi-Aventis: Lantus provides further blood-sugar reduction for patients with Type 2 diabetes
PARIS An injected insulin made by French drug maker Sanofi-Aventis provided further reduction of blood sugar in patients with Type 2 diabetes when added to oral diabetes drugs, according to a study presented at a medical conference in Sweden.
Sanofi announced Monday results of two studies presented at the European Association for the Study of Diabetes’ 46th annual meeting in Stockholm showing that adding Lantus (insulin glargine [rDNA]) to oral antidiabetic therapies, such as metformin, in Type 2 diabetes patients with uncontrolled blood sugar reduced A1C levels further than the antidiabetic therapies alone and also produced lower risk of abnormally low blood sugar, known as hypoglycemia.
“Patients with Type 2 diabetes who used Lantus as monotherapy or added it to one baseline oral antidiabetic agent demonstrated a greater reduction in A1C with lower risk of hypoglycemia than those taking two OADs, with a most significant reduction when Lantus was added to metformin alone versus other OADs,” University of Vermont College of Medicine researcher and lead investigator in one of the studies Jack Leahy said. The “other OADs” to which Leahy referred were sulfonylurea and sulfonylurea combined with metformin.
Kmart Pharmacy kicks off flu prevention program
HOFFMAN ESTATES, Ill. — Kmart Pharmacy’s more than 900 walk-in flu clinics will be open through Nov. 15 for customers looking to purchase a seasonal flu vaccination.
Kmart customers can receive their flu shots for $25, while supplies last, from a trained practitioner, Kmart said. Additionally, the seasonal flu shots are free for Medicare Part B members. This year’s vaccine will protect against 2009 H1N1 and two other influenza viruses — an H3N2 virus and an influenza B virus. Furthermore, Kmart Pharmacy will offer the Fluzone High-Dose vaccine for patients ages 65 years and older for $45.
"Following a 2009 flu season that saw significant outbreaks, including the H1N1 virus, Kmart Pharmacy is encouraging customers to get their vaccinations early in the season, especially since there is an incubation period before becoming fully effective," said Robb Ayshford, divisional VP pharmacy administration for Kmart. "The Kmart Pharmacy walk-in flu clinics are family friendly, have knowledgeable on-site pharmacists that can answer flu- and health-related questions, and carry a range of supplies to help customers stay healthy during the winter season."